IDEX vs Enzyme — how do they compare? IDEX trades at Rp33.85 (market cap Rp74,11M, Rp36,08M 24h volume), while Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume). The key difference: Enzyme is the larger of the two by market cap, and IDEX's circulating supply is 1B IDEX versus 3,3M MLN for Enzyme. Which is the better fit depends on your goals — on Pluang, investors hold IDEX for 19 Days and Enzyme for 28 Days on average.
| IDEX | MLN | |
|---|---|---|
Market Cap | Rp74,11M | Rp134,13M |
Volume (24h) | Rp36,08M | Rp104,56M |
Circulating Supply | 1B IDEX | 3,3M MLN |
Typical Hold Time | 19 Days | 28 Days |
Signals from Pluang's Aura AI — not financial advice
IDEX token currently holds a market capitalization of Rp74.11 million with 1 million tokens in circulation, indicating a relatively small-cap cryptocurrency. The token shows a hold time of 19 days, suggesting moderate holding behavior among investors. Recent trading activity appears limited based on available metrics, with no significant price data provided for technical trend analysis. The ecosystem shows minimal recent protocol updates or major developments based on current information.
Overall outlook remains cautious due to limited market data and ecosystem activity. Key opportunities include potential growth if network adoption increases, while major risks include low liquidity, limited exchange presence, and typical cryptocurrency volatility. Investors should monitor for any upcoming protocol developments or exchange listings that could impact token utility and valuation.
Enzyme (MLN) currently holds a market capitalization of Rp134.13 million with a circulating supply of 3.3 million tokens. The asset shows moderate market activity with a hold time of 28 days indicating average investor retention. Recent market data suggests stable trading patterns within the decentralized finance ecosystem, though specific price action requires current exchange verification.
Outlook remains cautiously neutral given limited recent protocol updates. Key opportunities include potential DeFi ecosystem growth integration, while risks center on typical crypto volatility and regulatory uncertainty. Investors should monitor on-chain activity and exchange liquidity for clearer directional signals.
IDEX describes itself as the first hybrid liquidity DEX, merging an order book model with an automated market maker (AMM). It combines the speed and functionality of traditional order books with the security and liquidity of AMMs. By integrating an off-chain trading engine with on-chain trade settlement, IDEX offers a unique approach to decentralized exchanges.
Read more on IDEX →Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →